XOMA Royalty Corp. (XOMA)
$40.17+0.00%Close
SELLBEAR · day 7
Key stats
- Market cap
- $504M
- Beta
- 0.86
- P/E (TTM)
- 24.35
- 1W
- +0.00%
- 1M
- -4.11%
- vs SPY 1W
- +0.14%
- vs SPY 1M
- -6.61%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 20
- VALUE
- 20
- GROWTH
- 37
- GARP
- 9
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC18.1%
REV YoY-
ROE30.2%
EPS YoY-
ROA11.6%
GROSS93
OP14
NET87
[VALUATION]
P/E TTM24.35
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B4.23
P/FCF-
EV/EBITDA14.76
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E110.48
ALTMAN Z-
CURR RATIO3.59
ND/EBITDA-
BETA0.86
Company news
FAQ
- What is LOPJLB’s current signal on XOMA?
- LOPJLB’s latest quantitative signal on XOMA Royalty Corp. (XOMA) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is XOMA in?
- XOMA Royalty Corp. (XOMA) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does XOMA Royalty Corp. (XOMA) do?
- XOMA Royalty Corp. functions as a specialist in aggregating biotechnology royalties, with its operations extending across Europe, the United States, and the Asia Pacific region. The company is dedicated to fostering advancements in human health by collaborating with biotechnology firms. Its core business model involves acquiring the anticipated future economic benefits, such as royalties and mi…